Cellular and Molecular Neurobiology, 2024 · DOI: https://doi.org/10.1007/s10571-024-01519-9 · Published: November 23, 2024
After a spinal cord injury, glial cells, especially astrocytes, become dysfunctional, leading to the formation of a glial scar. This disruption initiates neuroinflammation, involving microglia, neutrophils, other glial cells, and cytokine production. There are two types of astrocytes, A1 and A2. A2 is protective, while A1 releases neurotoxins that further promote glial scar formation.
Understanding the timeline of gliosis and inflammatory cascades can help develop targeted therapies to enhance repair and regeneration in damaged neural tissue.
Future studies should focus on selectively modulating astrocyte phenotypes to control glial scar formation.
Targeted modulation in molecular signaling pathways can help restore the damaged blood-spinal cord barrier (BSCB) integrity, controlling glial scar formation.